Cargando…

Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection

Herpes simplex virus 2 (HSV-2) infects the genital mucosa and establishes a life-long infection in sensory ganglia. After primary infection HSV-2 may reactivate causing recurrent genital ulcerations. HSV-2 infection is prevalent, and globally more than 400 million individuals are infected. As clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Önnheim, Karin, Ekblad, Maria, Görander, Staffan, Bergström, Tomas, Liljeqvist, Jan-Åke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848603/ https://www.ncbi.nlm.nih.gov/pubmed/27110813 http://dx.doi.org/10.3390/v8040110

Ejemplares similares

Anti-Glycoprotein G Antibodies of Herpes Simplex Virus 2 Contribute to Complete Protection after Vaccination in Mice and Induce Antibody-Dependent Cellular Cytotoxicity and Complement-Mediated Cytolysis
por: Görander, Staffan, et al.
Publicado: (2014)

Herpes Simplex Virus Type 2 Mucin-Like Glycoprotein mgG Promotes Virus Release from the Surface of Infected Cells
por: Trybala, Edward, et al.
Publicado: (2021)

A Genome-Wide Comparative Evolutionary Analysis of Herpes Simplex Virus Type 1 and Varicella Zoster Virus
por: Norberg, Peter, et al.
Publicado: (2011)

Rad51 and Rad52 Are Involved in Homologous Recombination of Replicating Herpes Simplex Virus DNA
por: Tang, Ka-Wei, et al.
Publicado: (2014)

Immunity to Ocular and Genital Herpes Simplex Viruses Infections
por: Chentoufi, Aziz Alami, et al.
Publicado: (2012)

Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections
por: Chentoufi, Aziz Alami, et al.
Publicado: (2012)

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
por: Egan, Kevin, et al.
Publicado: (2020)

Diagnosis of genital herpes simplex virus infection in the clinical laboratory
por: LeGoff, Jérôme, et al.
Publicado: (2014)

Secreted herpes simplex virus-2 glycoprotein G alters thermal pain sensitivity by modifying NGF effects on TRPV1
por: Cabrera, Jorge Rubén, et al.
Publicado: (2016)

Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs
por: Hook, Lauren M., et al.
Publicado: (2018)

CCL19 and CCL28 Assist Herpes Simplex Virus 2 Glycoprotein D To Induce Protective Systemic Immunity against Genital Viral Challenge
por: Yan, Yan, et al.
Publicado: (2021)

A Single gD Glycoprotein Can Mediate Infection by Herpes simplex Virus
por: Clarke, Richard W., et al.
Publicado: (2013)

Identification of the Cleavage Domain within Glycoprotein G of Herpes Simplex Virus Type 2
por: Kropp, Kai A., et al.
Publicado: (2020)

The prefusion structure of herpes simplex virus glycoprotein B
por: Vollmer, B., et al.
Publicado: (2020)

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
por: Egan, Kevin P., et al.
Publicado: (2020)

Herpes Simplex Virus 2 ICP0(−) Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine
por: Halford, William P., et al.
Publicado: (2010)

A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model
por: Awasthi, Sita, et al.
Publicado: (2017)

Erratum to: Diagnosis of genital herpes simplex virus infection in the clinical laboratory
por: LeGoff, Jérôme, et al.
Publicado: (2015)

Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus
por: Skinner, G. R. B., et al.
Publicado: (1980)

Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial
por: Bernstein, David I., et al.
Publicado: (2017)

Secreted Herpes Simplex Virus-2 Glycoprotein G Modifies NGF-TrkA Signaling to Attract Free Nerve Endings to the Site of Infection
por: Cabrera, Jorge Rubén, et al.
Publicado: (2015)

Aseptic Viral Meningitis Secondary to Herpes Simplex Virus 2 Genital Infection
por: Marshall, Camille, et al.
Publicado: (2021)

Successful Confirmation of Dual Genital Herpes Co-Infection with Herpes Simplex Virus 1 and Herpes Simplex Virus 2 Using Unbiased Metagenomic Next-Generation Sequencing
por: Lee, Chun Kiat, et al.
Publicado: (2023)

Tetherin Restricts Herpes Simplex Virus 1 and Is Antagonized by Glycoprotein M
por: Blondeau, Caroline, et al.
Publicado: (2013)

Developments in Vaccination for Herpes Simplex Virus
por: Krishnan, Rohini, et al.
Publicado: (2021)

Leflunomide in the Treatment of a Pseudotumoral Genital Herpes Simplex Virus Infection in an HIV Patient
por: Roger, Marie R., et al.
Publicado: (2017)

Increased level of compleasomes in cerebrospinal fluid of patients with herpes simplex encephalitis
por: Johansson, Ewa, et al.
Publicado: (2018)

Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2
por: Luo, Chenhong, et al.
Publicado: (2012)

Cellular Chondroitin Sulfate and the Mucin-like Domain of Viral Glycoprotein C Promote Diffusion of Herpes Simplex Virus 1 While Heparan Sulfate Restricts Mobility
por: Abidine, Yara, et al.
Publicado: (2022)

Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease
por: Petro, Christopher, et al.
Publicado: (2015)

A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
por: Kuraoka, Masayuki, et al.
Publicado: (2023)

Herpes Simplex Virus Glycoprotein C Regulates Low-pH Entry
por: Komala Sari, Tri, et al.
Publicado: (2020)

O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus
por: Johnson, David C., et al.
Publicado: (1983)

Herpes genital .
por: Rivera Gómez, Jesús
Publicado: (1996)

Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection
por: Calla, Nirk E Quispe, et al.
Publicado: (2016)

Genital Infection with Herpes Simplex Virus Types 1 and 2 in Women from Natal, Brazil
por: Miranda, Cleine Aglacy Nunes, et al.
Publicado: (2014)

Greater Durability and Protection against Herpes Simplex Viral Disease following Immunization of Mice with Single-Cycle ΔgD-2 Compared to an Adjuvanted Glycoprotein D Protein Vaccine
por: Mahant, Aakash Mahant, et al.
Publicado: (2023)

Vaccines against Genital Herpes: Where Are We?
por: Kim, Hyeon Cheol, et al.
Publicado: (2020)

An mRNA vaccine to prevent genital herpes
por: Awasthi, Sita, et al.
Publicado: (2022)

Immunogenicity and Efficacy of Intramuscular Replication-Defective and Subunit Vaccines against Herpes Simplex Virus Type 2 in the Mouse Genital Model
por: Delagrave, Simon, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9ekeml5lper39jtvea1kdi7jt5